Vancomycin

"Vancomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.

Descriptor ID	D014640
MeSH Number(s)	D09.400.420.925 D12.644.233.925
Concept/Terms	Vancomycin Vancomycin Vancomycin Hydrochloride Vancomycin Hydrochloride Hydrochloride, Vancomycin Vancomycin Sulfate Vancomycin Sulfate Sulfate, Vancomycin Vancomycin-ratiopharm Vancomycin-ratiopharm Vancomycin Hexal Vancomycin Hexal Vancomycine Dakota Vancomycine Dakota AB-Vancomycin AB-Vancomycin Vanco Azupharma Vanco Azupharma Diatracin Diatracin VANCO-cell VANCO-cell Vanco-saar Vanco-saar Vancocin Vancocin Vancocin HCl Vancomycin Lilly Vancocine Vancomicina Abbott Vancomicina Abbott Vancomicina Chiesi Vancomicina Chiesi Vancomicina Combino Phar Vancomicina Combino Phar Vancomicina Norman Vancomicina Norman Vancomycin Phosphate (1:2) Vancomycin Phosphate (1:2) Vancomycin Phosphate (1:2), Decahydrate Vancomycin Phosphate (1:2), Decahydrate

Below are MeSH descriptors whose meaning is more general than "Vancomycin".

Chemicals and Drugs [D]
Carbohydrates [D09]
Glycoconjugates [D09.400]
Glycopeptides [D09.400.420]
Vancomycin [D09.400.420.925]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Glycopeptides [D12.644.233]
Vancomycin [D12.644.233.925]

Below are MeSH descriptors whose meaning is related to "Vancomycin".

Below are MeSH descriptors whose meaning is more specific than "Vancomycin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vancomycin" by people in this website by year, and whether "Vancomycin" was a major or minor topic of these publications.

Bar chart showing 33 publications over 18 distinct years, with a maximum of 4 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1998	1	0	1
1999	1	1	2
2005	0	1	1
2006	0	1	1
2008	1	1	2
2010	1	0	1
2011	0	1	1
2012	0	1	1
2013	3	0	3
2014	2	1	3
2015	1	1	2
2016	3	1	4
2018	2	1	3
2019	1	1	2
2020	1	1	2
2023	2	0	2
2024	1	0	1

Below are the most recent publications written about "Vancomycin" by people in Profiles.

Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium. Aliment Pharmacol Ther. 2024 05; 59(10):1236-1247.

View in: PubMed
Lin IF, Lai CH, Lin SY, Lee CC, Lee NY, Liu PY, Yang CH, Huang YH, Lin JN. In Vitro and In Vivo Antimicrobial Activities of Vancomycin and Rifampin against Elizabethkingia anophelis. Int J Mol Sci. 2023 Nov 30; 24(23).

View in: PubMed
Skelly JD, Chen F, Chang SY, Ujjwal RR, Ghimire A, Ayers DC, Song J. Modulating On-Demand Release of Vancomycin from Implant Coatings via Chemical Modification of a Micrococcal Nuclease-Sensitive Oligonucleotide Linker. ACS Appl Mater Interfaces. 2023 Aug 09; 15(31):37174-37183.

View in: PubMed
Jahan F, Zaman SU, Syed MA, Arshad R, Amjad O, Ali I, Gul R, Shahnaz G, Aamir MN, Hanif S. HPLC method development and validation for in vitro and in vivo quantification of vancomycin in rabbit plasma. Pak J Pharm Sci. 2022 Nov; 35(6(Special)):1683-1690.

View in: PubMed
Rios R, Reyes J, Carvajal LP, Rincon S, Panesso D, Echeverri AM, Dinh A, Kolokotronis SO, Narechania A, Tran TT, Munita JM, Murray BE, Planet PJ, Arias CA, Diaz L. Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure. Sci Rep. 2020 03 27; 10(1):5636.

View in: PubMed
Sahu KK, Tsitsilianos N, Moselle L, Mishra AK. Septic arthritis of hip joint and its devastating complications. BMJ Case Rep. 2020 Feb 11; 13(2).

View in: PubMed
Zhang B, Braun BM, Skelly JD, Ayers DC, Song J. Significant Suppression of Staphylococcus aureus Colonization on Intramedullary Ti6Al4V Implants Surface-Grafted with Vancomycin-Bearing Polymer Brushes. ACS Appl Mater Interfaces. 2019 Aug 14; 11(32):28641-28647.

View in: PubMed
Caroff DA, Menchaca JT, Zhang Z, Rhee C, Calderwood MS, Kubiak DW, Yokoe DS, Klompas M. Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses. Infect Control Hosp Epidemiol. 2019 06; 40(6):662-667.

View in: PubMed
Hamel MS, Has P, Datkhaeva I, Delacy K, Ciolfi D, Hughes B. The Effect of Intrapartum Vancomycin on Vaginal Group B Streptococcus Colony Counts. Am J Perinatol. 2019 05; 36(6):555-560.

View in: PubMed
Lander HL, Ejiofor JI, McGurk S, Kaneko T, Shekar P, Xu X, Body SC. Vancomycin paste still does not reduce the incidence of deep sternal wound infection after cardiac surgery. J Thorac Cardiovasc Surg. 2018 09; 156(3):1125-1126.

View in: PubMed

People

Explore

Similar Concepts

Top Journals